SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,515.43 362.57
( 0.48%)

Global Indices

Nasdaq

53,423.66 -283.45
(-0.53%)

Dow Jones

7,737.34 -31.37
(-0.40%)

Hang Seng

65,002.68 788.20
(1.23%)

Nikkei 225

10,828.70 -2.82
(-0.03%)

Forex

USD-INR

94.48 -0.24
(-0.26%)

EUR-INR

109.71 0.00
(0.00%)

GBP-INR

127.63 -0.19
(-0.15%)

JPY-INR

0.60 0.01
(1.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533573

INE901L01018

285.6722314

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

APLLTD

20.12

15878.37

EPS(TTM)

Face Value()

Div & Yield %

40.14

1.49

Back

Rajkamal Synthetics reports standalone net profit of Rs 0.05 crore in the December 2025 quarter

Mar 10,2026

Net profit of Rajkamal Synthetics reported to Rs 0.05 crore in the quarter ended December 2025 as against net loss of Rs 0.07 crore during the previous quarter ended December 2024. Sales rose 2560.00% to Rs 1.33 crore in the quarter ended December 2025 as against Rs 0.05 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1.33	0.05	2560
OPM %	6.77	-140.00	-
PBDT	0.09	-0.07	LP
PBT	0.07	-0.07	LP
NP	0.05	-0.07	LP

76,515.43 362.57 ( 0.48%)

53,423.66 -283.45 (-0.53%)

7,737.34 -31.37 (-0.40%)

65,002.68 788.20 (1.23%)

10,828.70 -2.82 (-0.03%)

94.48 -0.24 (-0.26%)

109.71 0.00 (0.00%)

127.63 -0.19 (-0.15%)

0.60 0.01 (1.60%)